Renaissance Technologies - CELLULAR BIOMEDICINE GROUP I ownership

Back to all holdings Add to watchlist

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q2 2020$359,000
+39.1%
24,000
+192.7%
0.00%
-100.0%
Q1 2015$258,000–8,200–0.00%–
 Download
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q3 2020.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders